RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
TMITX
Price
$10.11
Change
-$0.05 (-0.49%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs TMITX

Header iconRPTIX vs TMITX Comparison
Open Charts RPTIX vs TMITXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Transamerica Mid Cap Growth I3
Price$10.11
Change-$0.05 (-0.49%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs TMITX Comparison Chart
Loading...
VS
RPTIX vs. TMITX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and TMITX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. TMITX (144M). RPTIX pays higher dividends than TMITX: RPTIX (0.18) vs TMITX (0.00). RPTIX was incepted earlier than TMITX: RPTIX (9 years) vs TMITX (11 years). TMITX is a more actively managed with annual turnover of: 75.00 vs. RPTIX (21.70). TMITX has a lower initial minimum investment than RPTIX: TMITX (0) vs RPTIX (500000). TMITX annual gain was more profitable for investors over the last year : 26.53 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. TMITX (-1.75).
RPTIXTMITXRPTIX / TMITX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years11 years-
Gain YTD9.12711.58979%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B144M21,806%
Annual Yield % from dividends0.180.00-
Returns for 1 year14.8126.5356%
Returns for 3 years-13.57-33.1341%
Returns for 5 years15.09-1.75-863%
Returns for 10 yearsN/A-6.38-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp